On Aug. 10, the FDA said 4,586 devices were recalled because of sudden power failures, which can cause inadequate blood supply and death. Twenty-six complaints, zero injuries and zero deaths have been reported in the recall.
This is the fourth statement the FDA has published in 2023 about the devices. In February, the company notified customers to stop using the pumps because of unexpected shutdowns, the FDA said in separate posts.
The month prior, the FDA said Getinge/Datascope reported a risk of balloons breaking. As of Jan. 25, 134 complaints, 12 device shutdowns, four serious injuries and one death have been reported.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
